• Increase
  • Decrease
  • Normal

Current Size: 100%

  • International Affiliate Members at Ed Forum 2019
    IWMF International Affiliates

    IWMF President, Carl Harrington, and Elena Malunis, IWMF Vice President of Member Services, at the 2019 Ed Forum with International Affiliate members.

  • Peter DeNardis
    The IWMF Is Here to Help You!

    Click on the image to view a video of Peter DeNardis, IWMF Board Member, as he explains how the Foundation helps everyone affected by WM.

  • Ed Forum 2019
    Imagine a Cure

    We have a goal of raising $25,000,000 to support WM research and vital member services through both current gifts and legacy gifts.

  • Ed Forum 2019 in front of Philadelphia Art Museum
    Living with WM

    There are many patients with Waldenstrom’s macroglobulinemia (WM) who are living well and enjoying life with a degree of contentment that may seem surprising to others.

  • Ed Forum walk June 2019 in Philadelphia
    IWMF Members

    All photos on our site are of IWMF members. 

We support everyone affected by Waldenstrom's macroglobulinemia
while advancing the search for a cure.


June 20, 2019

The 2019 Ed Forum in Philadelphia, PA was a great success – with revolutionary firsts of live streaming & debate sessions. We look forward to seeing you at the 2020 Ed Forum.

June 18, 2019

Atrial fibrillation (Afib or AF) is a concern for patients using ibrutinib, as some 10% of WMers on ibrutinib may eventually develop it.


June 13, 2019

The IWMF is pleased to announce that Andrew Warden of WMozzies was presented with the 2019 Judith May Volunteer Award at the IWMF Educational Form in Philadelphia, PA.


June 27, 2019
11301 Domain Drive
Austin , TX
United States
June 29, 2019
1500 New Britain Ave
West Hartford , CT
United States
June 30, 2019
4200 Mercantile Drive, Suite 700
Lake Oswego , OR
United States
July 6, 2019
11-13 Cavendish Square
United Kingdom
July 20, 2019
11550 North Meridian Street
Carmel , IN
United States

This website is supported in part by unrestricted educational grants from Pharmacyclics LLC  and Janssen Biotech, Inc.